AMBU B Ambu A/S Class B

AMBU FINANCIAL CALENDAR FOR 2023/24

AMBU FINANCIAL CALENDAR FOR 2023/24

This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as the date of Ambu’s Annual General Meeting. 



2023

8 NOVEMBER 2023 Annual Report 2022/23
13 DECEMBER 2023 Annual General Meeting 2023



2024

30 JANUARY 2024 Earnings release Q1 2023/24
14 MAY 2024 Earnings release Q2 2023/24
30 AUGUST 2024 Earnings release Q3 2023/24
30 SEPTEMBER 2024 End of fiscal year 2023/24
5 NOVEMBER 2024 Annual Report 2023/24
4 DECEMBER 2024 Annual General Meeting 2024



The deadline for the inclusion of specific items on the agenda for the Annual General Meeting 2023 is 31 October 2023.





Ambu A/S

Baltorpbakken 13

2750 Ballerup

Denmark

Tel.

CVR no.: 63 64 49 19



CONTACT INFORMATION

Media

Tine Bjørn Schmidt

Head of Corporate Communications







Investors

Anders Hjort

Head of Investor Relations





ABOUT AMBU

Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,500 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.

Attachment



EN
29/09/2023

Underlying

AMBU BAmbu A/S Class B

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ambu A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
AMBU B AMBU A/S CLASS B
05/08/25 May 8, 2025 1 EN
Jesper Ingildsen
  • Jesper Ingildsen
Free Trial
AMBU B Ambu A/S Class ...

Ambu (Buy, TP: DKK144.00) - Possibly isolated softness

Q2 was below our forecast, but the softness might be isolated to Q2 on what could be Chinese competitors dumping stock ahead of tariffs, which could become a tailwind. Notably, the 2024/25 guidance was maintained and includes headwinds from FX and tariffs. We reiterate our BUY, but have cut our target price to DKK144 (155).

AMBU B AMBU A/S CLASS B
05/07/25 May 7, 2025 1 EN
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
AMBU B AMBU A/S CLASS B
05/07/25 May 7, 2025 1 EN
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
AMBU B AMBU A/S CLASS B
05/06/25 May 6, 2025 1 EN
Jesper Ingildsen
  • Jesper Ingildsen
Free Trial
AMBU B Ambu A/S Class ...

Ambu (Buy, TP: DKK155.00) - Another strong quarter

We forecast Ambu to have another strong quarter, with c14% organic growth (we are above consensus) and continued solid margin progression. Despite tariffs, we expect the company to maintain its full-year guidance, but possibly increase the top-line guidance later in the year. We will also look for comments on the impact of tariffs on margins in the coming years. We reiterate our BUY, but have lowered our target price to DKK155 (165).

AMBU B AMBU A/S CLASS B
05/02/25 May 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch